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Published research is critical for advancing medical knowledge. The purpose of this study was to evaluate the trends of published research in 
cardiovascular medicine.
Methods: We evaluated the characteristics of published articles on cardiovascular disease for the New England Journal of Medicine (NEJM), 
Journal of the American Medical Association (JAMA), Journal of the American College of Cardiology (JACC), and Circulation (CIRC) for the first six 
months of 1991, 2001, and 2011. The financial support for studies was identified and as an estimate of potential costs for clinical studies: study 
design, number of centers, duration of follow-up, and required testing were evaluated.
Results: For both CIRC and JACC, a significant increase in clinical studies was observed in 2001 with a decrease to 1991 levels in 2011 (CIRC: 
1991: 115; 2001: 229; 2011: 127; JACC: 1991: 162; 2001: 226, 2011: 138). Over the past 20 years, there has been a significant decrease in 
clinical studies emanating solely from the United States and an increase in clinical studies that received industry support (I)(Table). The complexity 
of clinical studies has increased over the last twenty years with significant increases in centers and patient numbers, more studies with follow-up 
(F/U) and F/U > 1 year (Table).
Conclusions: Over the past 20 years clinical research has become more global and more likely to be supported by industry. Clinical studies have 
become larger and more complex which may have important ramifications for cost of healthcare. 
USA I Center # Patient # F/U F/U > 1 y
CIRC 1991 57% 16% 4 662 27% 12%
2001 42% 14% 42 3,357 20% 14%
2011 46% 25% 167 22,550 24% 21%
JACC 1991 67% 9% 2 183 20% 10%
2001 33% 14% 13 2,087 38% 17%
2011 34% 25% 64 2,598 42% 26%
NEJM 1991 50% 10% 5 970 47% 16%
2001 55% 55% 47 1,284 75% 25%
2011 17% 67% 118 7,158 83% 67%
JAMA 1991 100% 7% 3 895 33% 13%
2001 70% 15% 50 13,633 62% 25%
2011 72% 17% 195 21,671 64% 28%
